BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow-to-Debt Ratio
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow-to-Debt Ratio of 0.18x as of September 2025, meaning its operating cash flow of Rs149.66 Million could theoretically repay 0% of its total liabilities (Rs844.30 Million) in one year. See financial flexibility index of BALAXI PHARMACEUTICALS LIMITED to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BALAXI PHARMACEUTICALS LIMITED Cash Flow-to-Debt Ratio (2013–2026)
Historical debt coverage capacity for BALAXI PHARMACEUTICALS LIMITED across 14 annual periods. For the full cash flow conversion analysis, see cash flow conversion of BALAXI PHARMACEUTICALS LIMITED.
Annual Cash Flow-to-Debt Ratio for BALAXI PHARMACEUTICALS LIMITED (2013–2026)
Year-by-year debt coverage analysis for BALAXI PHARMACEUTICALS LIMITED. Check BALAXI PHARMACEUTICALS LIMITED cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.09x | Rs-82.44 Million | Rs879.53 Million | ▲ +80.5% |
| 2025 | -0.48x | Rs-377.82 Million | Rs786.06 Million | ▼ -662.8% |
| 2024 | 0.09x | Rs48.66 Million | Rs569.79 Million | ▼ -20.2% |
| 2023 | 0.11x | Rs60.75 Million | Rs567.89 Million | ▼ -80.2% |
| 2022 | 0.54x | Rs341.44 Million | Rs633.07 Million | ▲ +603623.0% |
| 2021 | 0.00x | Rs31.00K | Rs347.00 Million | ▲ +100.0% |
| 2020 | -1.71x | Rs-140.62 Million | Rs82.25 Million | ▼ -193.5% |
| 2019 | -0.58x | Rs-15.07 Million | Rs25.87 Million | ▲ +88.7% |
| 2018 | -5.14x | Rs-6.78 Million | Rs1.32 Million | ▼ -12.7% |
| 2017 | -4.56x | Rs-9.91 Million | Rs2.17 Million | ▲ +83.4% |
| 2016 | -27.48x | Rs-1.16 Million | Rs42.12K | ▼ -159.4% |
| 2015 | 46.27x | Rs2.11 Million | Rs45.65K | ▲ +8299.8% |
| 2014 | -0.56x | Rs-2.39 Million | Rs4.24 Million | ▼ -184.5% |
| 2013 | 0.67x | Rs3.25 Million | Rs4.86 Million | — |